Martha Gulati and Kathyn Berlacher talk about tangible ways to improve women's cardiovascular care, including nontraditional, patient-centered solutions.

Clyde Yancy, Suzanne Baron, and Bruce Rutkin discuss ways to address the undertreatment of CVD in women at the patient, provider, structural, and societal levels.

Clyde Yancy talks to Sharonne Hayes and Robert Harrington about the barriers that have historically hindered diagnosing heart disease in women, including sex differences in disease presentation and outdated biases.

Clyde Yancy, Roxana Mehran, and Howard Herrmann discuss strategies for increasing clinical trial enrollment among women, including targeting disease phenotypes and sex-specific trials. Sponsored by Medtronic.

Clyde Yancy talks to Priya Freaney and Nisha Parikh about the landscape of cardiovascular care for women and how it can be improved, both for patients and women training to be cardiologists. Sponsored by Medtronic.

Sreek Vemulapalli and Roseann White explain the statistical challenges that can arise while collecting longer-term follow-up data during clinical trials.

Sreekanth Vemulapalli asks Ryan Ahern about potential data sources that can be used to sustain long-term follow-up in pivotal trials.

Vinod Thourani and Larry Epstein explore the current field of tricuspid intervention as well as challenges within lead management with additional commentary from Ami Bhatt.

Paul Sorajja and Vinod Thourani discuss the key considerations for choosing between transcatheter tricuspid repair and replacement.

Janar Sathananthan, Ole De Backer, and Michael Reardon dive into the newest findings on TAVR from the late-breaking ACURATE IDE trial.